Navigation Links
Researchers developing new multiple sclerosis drug that can be taken orally
Date:7/10/2012

The Department of Defense (DoD) has awarded SRI International a one-year grant to develop a novel therapy for multiple sclerosis (MS), an autoimmune nervous system disease that affects about 400,000 people in the United States and more than two million people worldwide. There is currently no cure for this disorder, which can impair vision and movement.

The grant, funded through DoD's Congressionally Directed Medical Research Programs, will support the development of an oral drug that targets miR-326, a molecule recently found to stimulate the production of immune system mediators known as T-helper 17 (Th17) cells. Patients with MS have high levels of miR-326, and Th17 is thought to play a critical role in causing MS and other autoimmune diseases. The new therapy will inhibit miR-326 and block the production of Th17 cells.

The novel, orally administered drug will be more convenient for patients than currently available treatments. MS treatments today often require frequent hospital visits for injections or intravenous infusions. The new drug could also help patients who do not respond to existing medications, or who experience significant side effects as a result of taking them.

"New and more convenient and effective therapeutics for multiple sclerosis are greatly needed," said Jennifer Lam, Ph.D., a research scientist in SRI's Biosciences Division who is spearheading the project. "Our research is directed toward the development of a novel oral therapeutic as well as a deeper understanding of the mechanisms that contribute to MS."

The project described was supported by Award Numbers W81XWH-11-1-0736 from the U.S. Army Medical Research Acquisition Activity. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred.


'/>"/>

Contact: Dina Basin
dina.basin@sri.com
650-859-3845
SRI International
Source:Eurekalert

Page: 1

Related medicine news :

1. UMass Amherst researchers unravel secrets of parasites replication
2. U-M researchers identify new genetic cause for chronic kidney disease
3. Researchers develop secure protocol for linking data registries for HPV surveillance
4. $53 million grant will help health researchers develop new therapies -- with the publics help
5. Researchers find new target deep within cancer cells
6. Researchers offer new approach to track former prisoners access to community HIV care
7. UTHealth, French researchers discover gene defect for new syndrome
8. New Facebook app to detect pedophiles and criminals developed by Ben-Gurion U. researchers
9. BWH researchers discover new vaccine candidate for Pseudomonas aeruginosa
10. Researchers will employ microscopic clay minerals to design more efficient and less toxic drugs
11. Tufts Medical Center researchers receive $10 million NIH grant to test blood clot prevention drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... Orion, Michigan (PRWEB) , ... ... ... a disease affecting the female reproductive tract in which the endometrial lining ... pelvic structures causing inflammation and pain. Patients experiencing painful intercourse, painful periods, ...
(Date:5/24/2017)... ... 24, 2017 , ... Rob Lowe is a sought after actor, and also ... brings the public important topics from all aspects of life, and a new segment ... surrounding feet and ankles. , Podiatry is essential to people’s overall well-being, and if ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand ... Integration company, announced today that its iClinic V12.2 solution has achieved approval from ... NCQA recently introduced PCMH 2017 standards which emphasize team-based care with a significant ...
(Date:5/23/2017)... , ... May 23, 2017 , ... New England Journal ... Crisis Worthy of a Policy Response”, -The Rory Staunton Foundation Calls on Health & ... for the Prevention of Sepsis ( http://www.rorystauntonfoundation.org ) today reported on a new study ...
(Date:5/23/2017)... ... May 23, 2017 , ... By all indications, and due to months of ... call for diligence, asking homeowners to scout for any open water sources that can ... the annoying buzz of mosquitos is the buzz associated with potential infections stemming from ...
Breaking Medicine News(10 mins):
(Date:5/3/2017)... May 3, 2017  West Pharmaceutical Services, Inc. ... for injectable drug administration, announced today that ... Technical Services, and Diane Paskiet , Director, ... presentations focused on West,s expertise in the areas ... well as providing commentary on updated industry guidance. ...
(Date:5/2/2017)... -- George Clinical, a leading full-service CRO in the ... a Memphis -based leader in ... George Clinical has acquired Vector Oncology,s Pharma Services (CRO) Division. ... of strengthening the ability of George Clinical to ... the Asia-Pacific , the world,s ...
(Date:5/2/2017)... , May 2, 2017  Bayer and Project Apis m. ... Healthy Hives 2020, a $1 million research effort to improve ... the end of 2020. The grant recipients ... , University of North Carolina at Greensboro, who will investigate ... Dr. Edmund Stark , Michigan State ...
Breaking Medicine Technology: